You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
31 July 2026 - Hong Kong-based biotechnology company IMPACT Therapeutics, Inc. (HKG: 7630) announced on Friday that it has entered an exclusive partnership with Pharmanovia, granting the global specialty pharmaceutical company rights to manufacture, ...
31 July 2026 - Datroway (datopotamab deruxtecan), jointly developed by Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) and British-Swedish biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN), has received European Un...
31 July 2026 - Karyopharm Therapeutics Inc (Nasdaq:KPTI), a commercial-stage pharmaceutical company developing novel cancer therapies, on Thursday announced topline results from its Phase 3 XPORT-EC-042 trial evaluating XPOVIO (selinexor) as a mainte...
31 July 2026 - Portugal-based Proteotype Diagnostics Unipessoal LDA on Thursday unveiled Alchemi, its proprietary data and clinical workflow platform being developed for Enlighten, the company's investigational blood-based multi-cancer test.Enli...
30 July 2026 - Stevanato Group S.p.A. (NYSE:STVN), a provider of drug containment, drug delivery and diagnostic solutions for the pharmaceutical, biotechnology and life sciences industries, announced on Thursday that liraglutide-based combination pro...
30 July 2026 - Life science technology company 10x Genomics Inc (Nasdaq:TXG) on Wednesday announced a research collaboration with Lausanne University Hospital (CHUV), a Swiss academic medical centre, to advance research in diagnostic applications of ...
29 July 2026 - US biopharmaceutical company AbbVie (NYSE: ABBV) said on Wednesday it has received European Commission approval for RINVOQ (upadacitinib) to treat adults and adolescents aged 12 and over with severe alopecia areata when taken once dail...